Chief Executive Officer
Wed, Feb 15, 2023
Feb 15
4,750 shares @ $0.00
Decreased holdings by -6.30%
Net across this filing: +0.40% (+5,290 shares)
122nd largest trade (out of 185)
Option ExercisePositive 90D History
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +0.4% (+5,290 shares)
62% win rate · -0.8% median edge vs SPY (13 trades, 90-day · small sample)
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology